ALFA Filings
Every announcement, straight from the exchange
Every Jagsonpal Pharmaceuticals other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Jagsonpal Pharmaceuticals Ltd filed its quarterly shareholding pattern statement in compliance with SEBI Regulation 31(1)(b).
The company informed shareholders without registered email addresses of the web-link to access the 2025-26 Annual Report and AGM Notice, per Regulation 36(1)(b).
Jagsonpal Pharmaceuticals filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The auditor reported nil non-compliances and no regulatory fines.